Among the12 patients with PD-L1–negative tumours, bestresponse was complete response for one patients with gastric cancer, stabledisease for two patients (one ESCC and one gastric cancer), and progressivedisease for nine patients (six ESCC and two gastric cancer). This evidence concerns the gene CD274 and gastric cancer.